B
Ben E. De Pauw
Researcher at Radboud University Nijmegen
Publications - 38
Citations - 9215
Ben E. De Pauw is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Clinical trial & Aspergillosis. The author has an hindex of 21, co-authored 38 publications receiving 8669 citations. Previous affiliations of Ben E. De Pauw include Harvard University.
Papers
More filters
Journal ArticleDOI
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben E. De Pauw,Thomas J. Walsh,J. Peter Donnelly,David A. Stevens,John E. Edwards,Thierry Calandra,Peter G. Pappas,Johan Maertens,Olivier Lortholary,Carol A. Kauffman,David W. Denning,Thomas F. Patterson,Georg Maschmeyer,Jacques Bille,William E. Dismukes,Raoul Herbrecht,William W. Hope,Christopher C. Kibbler,Bart Jan Kullberg,Kieren A. Marr,Patricia Muñoz,Frank C. Odds,John R. Perfect,Angela Restrepo,Markus Ruhnke,Brahm H. Segal,Jack D. Sobel,Tania C. Sorrell,Claudio Viscoli,John R. Wingard,Theoklis E. Zaoutis,John E. Bennett +31 more
TL;DR: These revised definitions of invasive fungal disease are intended to advance clinical and epidemiological research and may serve as a useful model for defining other infections in high-risk patients.
Journal ArticleDOI
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Raoul Herbrecht,David W. Denning,David W. Denning,Thomas F. Patterson,John E. Bennett,Reginald Greene,Reginald Greene,J. W. Oestmann,Winfried V. Kern,Winfried V. Kern,Winfried V. Kern,Kieren A. Marr,Patricia Ribaud,Olivier Lortholary,Richard J. Sylvester,Robert H. Rubin,John R. Wingard,Paul Stark,Christine Durand,Denis Caillot,Eckhard Thiel,Pranatharthi H. Chandrasekar,Michael R. Hodges,Haran T. Schlamm,Peter F. Troke,Ben E. De Pauw +25 more
TL;DR: In patients with invasive aspergillosis,Initial therapy with voriconazole led to better responses and improved survival and resulted in fewer severe side effects than the standard approach of initial therapy with amphotericin B.
Journal ArticleDOI
Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign
Reginald Greene,Haran T. Schlamm,J. W. Oestmann,Paul Stark,Christine M. Durand,Olivier Lortholary,John R. Wingard,Raoul Herbrecht,Patricia Ribaud,Thomas F. Patterson,Peter F. Troke,David W. Denning,John E. Bennett,Ben E. De Pauw,Robert H. Rubin +14 more
TL;DR: Initiation of antifungal treatment on the basis of the identification of a halo sign by chest CT is associated with a significantly better response to treatment and improved survival.
Journal ArticleDOI
Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
Brahm H. Segal,Raoul Herbrecht,David A. Stevens,David A. Stevens,Luis Ostrosky-Zeichner,Jack D. Sobel,Claudio Viscoli,Thomas J. Walsh,Johan Maertens,Thomas F. Patterson,John R. Perfect,Bertrand Dupont,John R. Wingard,Thierry Calandra,Carol A. Kauffman,John R. Graybill,Lindsey R. Baden,Peter G. Pappas,John E. Bennett,Dimitrios P. Kontoyiannis,Catherine Cordonnier,Maria Anna Viviani,Jacques Bille,Nikolaos G. Almyroudis,L. Joseph Wheat,Wolfgang Graninger,Eric J. Bow,Steven M. Holland,Bart Jan Kullberg,William E. Dismukes,Ben E. De Pauw +30 more
TL;DR: An expert international panel consisting of the Mycoses Study Group and the European Organization for Research and Treatment of Cancer was convened to propose guidelines for assessing treatment responses in clinical trials of IFDs and for defining study outcomes.
Journal ArticleDOI
Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.
Ludy C. H. W. Lutgens,Nicole M. A. Blijlevens,Nicolaas E. P. Deutz,J. Peter Donnelly,Philippe Lambin,Ben E. De Pauw +5 more
TL;DR: The authors investigated the characteristics of serum citrulline concentration compared with sugar permeability tests with respect to its use as a marker for cancer treatment‐induced small bowel injury.